Target intelligence / Profile preview

Immune system (Antigen-presenting cells, B cells, and T cells)

Molecular classification
Other
01

Overview

The immune system components mentioned—antigen-presenting cells (APCs), B cells, and T cells—constitute the fundamental units of the adaptive immune response. APCs, including dendritic cells and macrophages, capture and process antigens to present them to T cells via MHC molecules, initiating a specific immune response (StatPearls: Physiology, Antigen Presenting Cells). T cells are responsible for cell-mediated immunity, including the direct killing of infected or cancerous cells and the coordination of other immune cells, while B cells mediate humoral immunity through the production of highly specific antibodies (NIH: Overview of the Immune System). Although this entry describes a collection of cell types rather than a single molecular target, these cells express a wide array of therapeutic targets such as CD20, PD-1, and CTLA-4. Drugs interacting with these cells range from immunosuppressants used in transplantation to checkpoint inhibitors and CAR-T cell therapies used in oncology (PubMed: PMC7358244). Dysregulation of these cells is a hallmark of numerous pathologies, including autoimmune diseases, chronic inflammation, and various malignancies.

Other names
Adaptive immune systemCellular and humoral immunityLymphocytes and APCs
02

Mechanism of action

Modulation of immune cell activity through binding of specific surface antigens, checkpoint inhibition, or suppression of intracellular signaling pathways.

03

Biological functions

Immune responseAntigen presentationAntibody productionCell-mediated immunityImmunological memory
04

Disease associations

CancerAutoimmune diseaseInfectionInflammationImmunodeficiency
05

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Opportunistic infectionsAnaphylaxisGraft-versus-host disease
06

Interacting drugs

Rituximab

5 more in the full profile.

07

Biomarkers

CD3CD4CD8CD19CD20HLA-DRCytokine levels

Beyond the preview

Go deeper on Immune system (Antigen-presenting cells, B cells, and T cells).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system (Antigen-presenting cells, B cells, and T cells).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call